Skip to main navigation Skip to search Skip to main content

Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation: NOAH-AFNET 6

  • Andreas Goette
  • , Marc D. Lemoine
  • , Alexander Fierenz
  • , Emanuele Bertaglia
  • , Vincent Beuger
  • , Carina Blomstrom-Lundqvist
  • , Axel Brandes
  • , Melanie Calvert
  • , A. John Camm
  • , Gregory Chlouverakis
  • , Gheorghe-Andrei Dan
  • , Wolfgang Dichtl
  • , Hans Christoph Diener
  • , Joris R. de Groot
  • , Lieven Nils Kennes
  • , Gregory Y. H. Lip
  • , Andrzej Lubinski
  • , Eloi Marijon
  • , Bela Merkely
  • , Lluis Mont
  • Kim Rajappan, Andrea Sarkozy, Ulrich Schotten, Emmanuel Simantirakis, Tobias Toennis, Panos Vardas, Vasil Velchev, Dan Wichterle, Stephan Willems, Antonia Zapf, Paulus Kirchhof*, NOAH-AFNET 6 investigators
*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Article numbereuag083
Number of pages5
JournalEP Europace
Volume28
Issue number4
DOIs
Publication statusPublished - 1 Apr 2026

Keywords

  • Anticoagulation
  • Chronic kidney disease
  • Risk prediction
  • Device-detected atrial fibrillation
  • Bleeding
  • OUTCOMES
  • IMPACT

Cite this